Statin use for primary prevention: USPSTF criteria applies to which group?

• A. Adults aged 40 to 75 with 1+ risk factors and an estimated 10-year risk of 10% or greater.
• B. Adults aged 18 to 39 with no risk factors.
• C. All adults regardless of risk.
• D. Adults over 75.

Answer: (A)

The key idea is identifying who benefits most from statin therapy for primary prevention based on age, risk factors, and estimated short-term cardiovascular risk. USPSTF guidance targets adults who are old enough to have meaningful short-term risk but not so old that the balance of benefits and harms becomes uncertain, and it uses a calculated 10-year ASCVD risk to decide who should start therapy.

Specifically, statins for primary prevention are recommended for adults aged 40 to 75 who have at least one risk factor (such as high LDL cholesterol, high blood pressure, diabetes, smoking, or a family history of premature ASCVD) and whose estimated 10-year ASCVD risk is 10% or greater. The risk calculation helps identify those with a high enough absolute risk that the potential benefit of statins justifies treatment, while avoiding unnecessary treatment in low-risk individuals.

This criteria set does not apply to younger adults (18–39) with no risk factors, who generally have a low absolute risk, nor to all adults regardless of risk, and it’s not a blanket recommendation for adults over 75, where evidence and decision-making are more individualized.